LoopLab Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $45.2M

  • Investors
  • 1

LoopLab Bio General Information

Description

Developer of a biotechnology platform designed to selectively modulate disease-causing immune responses while preserving protective immunity. The company offers antigen-specific targeting and FcγRIIB-mediated immune modulation for antibody-driven diseases, enabling pharmaceutical and biotechnology companies to develop therapies for autoimmune diseases, allergies, and the prevention of anti-drug antibodies.

Contact Information

Website
www.looplab.bio
Formerly Known As
LL Zweite Bio GmbH
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Muthgasse 11
  • Vienna, Vienna 1190
  • Austria
+43 01
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Muthgasse 11
  • Vienna, Vienna 1190
  • Austria
+43 01

LoopLab Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LoopLab Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 02-Sep-2026 $45.2M In Progress Pre-Clinical Trials
3. Grant 01-Apr-2026 Completed Pre-Clinical Trials
2. Seed Round 01-Apr-2026 $11.1M $11.1M Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2026 Completed Pre-Clinical Trials
To view LoopLab Bio’s complete valuation and funding history, request access »

LoopLab Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to selectively modulate disease-causing immune responses while preserving
Biotechnology
Vienna, Austria
19 As of 2026

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LoopLab Bio Competitors (1)

One of LoopLab Bio’s competitors is Merida Biosciences, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merida Biosciences Formerly VC-backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

LoopLab Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LoopLab Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Incubator Network Accelerator/Incubator
To view LoopLab Bio’s complete investors history, request access »

LoopLab Bio FAQs

  • When was LoopLab Bio founded?

    LoopLab Bio was founded in 2023.

  • Where is LoopLab Bio headquartered?

    LoopLab Bio is headquartered in Vienna, Austria.

  • What is the size of LoopLab Bio?

    LoopLab Bio has 19 total employees.

  • What industry is LoopLab Bio in?

    LoopLab Bio’s primary industry is Biotechnology.

  • Is LoopLab Bio a private or public company?

    LoopLab Bio is a Private company.

  • What is LoopLab Bio’s current revenue?

    The current revenue for LoopLab Bio is .

  • How much funding has LoopLab Bio raised over time?

    LoopLab Bio has raised $11.1M.

  • Who are LoopLab Bio’s investors?

    Global Incubator Network has invested in LoopLab Bio.

  • Who are LoopLab Bio’s competitors?

    Merida Biosciences is a competitor of LoopLab Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process